Abacavir compound sulfate, identified by the chemical designation 188062-50-2, represents a crucial agent reverse transcriptase utilized in the treatment of HIV diseases. Its structural weight is approximately 359.36 g/mol, exhibiting a crystalline structure and a moderate solubility. The key ingredient functions by inhibiting the viral factor, the